Pfizer Inc
PFENYSEPharmaceutical PreparationsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 28, 2026Last filing: 10-Q on Aug 4, 2026Score 11/3053% above fair value
$30.67+0.15 (+0.49%)
Close on Nov 2, 2026Market cap $174.81BP/E 40.4Yield 5.61%
Pfizer China — Share of consolidated total revenues by Year
China — Share of consolidated total revenues (%) (%)
Pfizer China — Share of consolidated total revenues: 5.0% in FY2025, up 1.0 pts from a year earlier.
Latest, FY2025
5.0%
Period ended Dec 31, 2025
Change on a year earlier
+1.0 pts
4.0% in FY2024
History
6 years
Since FY2017
Sources
3
Documents cited below
Where the FY2025 figure comes from
Source: Form 10-K (filed 2026-02-26) ↗
Reported in Form 10-K Note 17 — Significant Customers & Geographic Concentration.
Annual history
Hover a value to see the sentence it was read from; calculated values show their formula
| Period | Ended | China — Share of consolidated total revenues (%) (%) | Year on year | Source |
|---|---|---|---|---|
| FY2025 | Dec 31, 2025 | 5.0% | +1.0 pts | Form 10-K (filed 2026-02-26) ↗ |
| FY2024 | Dec 31, 2024 | 4.0% | – | Form 10-K (filed 2026-02-26) ↗ |
| FY2020 | Dec 31, 2020 | 6.0% | 0.0 pts | Form 10-K (filed 2021-02-25) ↗ |
| FY2019 | Dec 31, 2019 | 6.0% | 0.0 pts | Form 10-K (filed 2021-02-25) ↗ |
| FY2018 | Dec 31, 2018 | 6.0% | -1.0 pts | Form 10-K (filed 2021-02-25) ↗ |
| FY2017 | Dec 31, 2017 | 7.0% | – | Form 10-K (filed 2020-02-27) ↗ |
Cite this data
StockData. (2026). Pfizer China — Share of consolidated total revenues (%), annual FY2017–FY2025 [Data set]. Compiled from Pfizer SEC filings and investor materials. https://stockdatahq.com/stocks/pfe/kpis/conc-geo-cn
See every metric in the Pfizer KPI table. Data updated Nov 2, 2026.